China securities net news (reporter Wang Yi) Fu'an pharmaceutical 30 days notice, the company's sterile APIs -- Cefmetazole sodium recently received the Chongqing Municipal Food and Drug Administration issued the "drug" GMP certificate, the period from April 25, 2014 to April 24, 2019. The company said, Cefmetazole sodium raw material medicine obtained the GMP Certificate in this post will be able to contribute to the production, sales, product variety, product structure optimization. But the specific performance of the products by the market environment changes and other uncertain factors, uncertainty.

 

The first quarter of this year, Fu'an pharmaceutical industry to achieve operating income 111000000 yuan, net profit of 16420000 yuan, a year-on-year growth of 14.92% and 4.49% respectively. After 3 years of performance decline period, showed "signs of bottoming out". The company said, mainly for the new approved varieties, with the continued marketing, the sales growth of revenue increase, product gross margin contribution."